YU JOHN S (CEO and Chairman) purchased 0.1% of their position (4K shares) of KAIROS PHARMA, LTD. on the open market
Open‑market purchase worth $5.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/21/2024ACC: 0001493152-24-047261
DirectorOfficer10% Owner· CEO and Chairman
Since Sep 2024
+4K
Net shares
Net buyer
$5.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4K acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+4K
Price / share
$1.44
Trade value
$5.76K
% of position
0.1%
11/20/2024
5.34M→5.34M
Total
Net shares
+4K
Net value
$5.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 11/20/2024 | P · Purchase | +4K | $1.44 | $5.76K | 0.1% | 5.34M | 5.34M |
| Total | +4K | $5.76K | ||||||
Derivative Transactions0
No derivative transactions reported